OR WAIT null SECS
April 02, 2009
The financial and economic downturn is likey to have long-term implications for outsourcing.
April 01, 2009
The authors examine common superdisintegrants (i.e., crospovidone Type A, crospovidone Type B, croscarmellose sodium, and sodium starch glycolate) with a set of poorly soluble drug actives and evaluate in vitro drug dissolution.
March 26, 2009
Also, Hospira to reduce workforce; WuXi AppTech makes senior appointments; more...
March 19, 2009
Also, Genzyme receives warning letter; Mesa Laboratories appoints John J. Sullivan CEO and a member of the board of directors; more...
March 12, 2009
Also, Penn Pharma to expand; stem cell research funding ban lifted; Bristol-Myers Squibb made senior appointments; more...
March 05, 2009
Also, Schering-Plough's vaccine unit, Nobilon, formed an agreement with the World Health Organization; Ore Pharmaceuticals named president and CEO; more...
March 02, 2009
Industry has changed, but its basic tenets have not. INTERPHEX's RJ Palermo discusses a 7-step process to keep pharma moving forward.
Contract manufacturers of APIs and intermediates report gains, but express caution.
February 26, 2009
Also, GPC Biotech AG and Agennix to merge; BASi appoints COO of scientific services; more...
February 19, 2009
Also, Sandoz received approval for its third biosimilar from the EU, WuXi PharmaTech's CFO Benson Tsang to leave at month's end; more...